首页> 外文期刊>Theriogenology >Trichostatin A alters the expression of cell cycle controlling genes and microRNAs in donor cells and subsequently improves the yield and quality of cloned bovine embryos in vitro
【24h】

Trichostatin A alters the expression of cell cycle controlling genes and microRNAs in donor cells and subsequently improves the yield and quality of cloned bovine embryos in vitro

机译:Trichostatin A改变供体细胞中细胞周期控制基因和microRNA的表达,从而提高体外克隆的牛胚胎的产量和质量

获取原文
获取原文并翻译 | 示例
           

摘要

Trichostatin A (TSA), a histone deacetylase inhibitor, has been used to improve nuclear reprogramming in somatic cell nuclear transfer embryos. However, the molecular mechanism of TSA for the improvement of the pre- and postimplantation embryonic development is unknown. In the present study, we investigated mechanism of cell cycle arrest caused by TSA and also determined embryo quality and gene expression in cloned bovine embryos produced from TSA-treated donor cells compared with embryos produced by in vitro fertilization or parthenogenetic activation. We observed that, 50 nM TSA-treated cells were synchronized at G0/G1 stage with concomitant decrease in the proportion of these cells in the S stage of the cell cycle, which was also supported by significant changes in cell morphology and decreased proliferation (P 0.05). Measurement of relative expression using real-time polymerase chain reaction of a some cell cycle-related genes and microRNAs in treated donor cells showed decreased expression of HDAC1, DNMT1, P53, CYC E1, and CDK4 and increased expression of DNMT3a, CDKN1A, CDK2, CDK3, miR-15a, miR-16, and miR-34a (P 0.05). No change in the relative expression of miR-449a was noticed. Trichostatin A treatment of donor cells significantly improved both cleavage and blastocyst rate (P 0.05) compared with the control embryos, also apoptotic index in treated cloned blastocysts was significantly decreased compared with the nontreated blastocysts (P 0.05) and was at the level of IVF counterpart. Relative expression of HDAC1 and DNMT3a was significantly lower in treated cloned and parthenogenetic embryos than that of nontreated and IVF counterpart, whereas in case of P53, expression level between treated and IVF embryos was similar, which was significantly lower than nontreated cloned and parthenogenetic embryos. In conclusion, our data suggested that TSA improves yield and quality of cloned bovine embryos by modulating the expression of G0/G1 cell cycle stage-related microRNA in donor cells, which support that TSA might be great cell cycle synchronizer apart from potent epigenetic modulator in cloning research in future. Crown Copyright (C) 2014 Published by Elsevier Inc. All rights reserved.
机译:组蛋白脱乙酰基酶抑制剂曲古他汀A(TSA)已用于改善体细胞核移植胚胎中的核重编程。但是,TSA改善植入前和植入后胚胎发育的分子机制尚不清楚。在本研究中,我们调查了由TSA引起的细胞周期停滞的机制,并且还确定了与通过体外受精或孤雌生殖激活产生的胚胎相比,由TSA处理的供体细胞产生的克隆牛胚胎的胚胎质量和基因表达。我们观察到,在G0 / G1阶段同步处理了50 nM TSA处理的细胞,同时在细胞周期的S阶段同时减少了这些细胞的比例,这也得到了细胞形态的显着变化和增殖减少的支持(P <0.05)。使用处理的供体细胞中一些细胞周期相关基因和microRNA的实时聚合酶链反应测量相对表达,结果显示HDAC1,DNMT1,P53,CYC E1和CDK4的表达降低,而DNMT3a,CDKN1A,CDK2, CDK3,miR-15a,miR-16和miR-34a(P <0.05)。没有观察到miR-449a的相对表达的变化。曲古他汀A处理供体细胞与对照胚胎相比均显着改善了卵裂和胚泡率(P <0.05),与未处理的胚泡相比,经处理的克隆胚泡的凋亡指数也显着降低(P <0.05),并且处于试管婴儿。在处理过的克隆和孤雌生殖胚胎中,HDAC1和DNMT3a的相对表达显着低于未处理和IVF对应的胚胎,而在P53的情况下,处理过的与IVF胚胎之间的表达水平相似,这显着低于未处理的克隆和孤雌性胚胎。总之,我们的数据表明,TSA通过调节供体细胞中G0 / G1细胞周期阶段相关的microRNA的表达来提高克隆的牛胚胎的产量和质量,这支持TSA可能是强力的表观遗传调节剂之外的重要细胞周期同步器。将来进行克隆研究。 Crown版权所有(C)2014,Elsevier Inc.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号